{
    "2019-08-22": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Top Research Reports for Union Pacific, Lowe's & Gilead",
                "features": {
                    "keywords": [
                        "Union Pacific",
                        "Lowe's",
                        "Gilead"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "transportation",
                        "retail",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Union Pacific Stock Up 22% YTD on Cost Cut & Other Factors",
                "features": {
                    "keywords": [
                        "Union Pacific",
                        "Stock Up",
                        "Cost Cut",
                        "Other Factors"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "transportation"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "Jim Cramer Weighs In On Pfizer, Teva And More",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "Pfizer",
                        "Teva"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}